Monday, Nov 18, 2024 · SEC filings
What the smart money revealed on Nov 18
666 insider filings came in. We hid 75 planned (10b5-1) sellers and 396 people whose filings were routine, like grants and tax withholding.
6 insiders at Zeta Global (ZETA) bought $2.64M of stock
Roles: CEO, President, CFO, Director. Several insiders buying in the same few days is rare.
Cartesian Therapeutics (RNAC) Director Timothy Springer bought $7.37M
431,940 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 8 checked quarters beat the typical stock 6 months later.
Oscar Health (OSCR) Co-Founder and Vice Chairman Joshua Kushner bought $5.44M
344,522 shares on the open market. Not a grant or an option exercise.
Prospect Capital (PSEC) CEO John Barry bought $4.37M
1M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
Grocery Outlet Holding (GO) Director Erik Ragatz bought $2.01M
110,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
V2X (VVX) Director Dino Cusumano sold $145M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 13.7M shares.
Rocket Lab USA (RKLB) Director Matthew Ocko sold $96.8M
Not marked as a planned 10b5-1 sale. Sold 53% of the shares they held directly. Still holds 4.77M shares.
Q2 (QTWO) Director Jeffrey Diehl sold $3.88M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 63 more real buys
Show 85 more real sales
13F season
Holdings as of Sep 30, 2024 were due Nov 14
58 funds have filed. 54 filed for the quarter before.
Biggest real insider buys, Nov 12–18
Open-market buys by officers and directors, filed in the 7 days up to Nov 18.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.